Buprenorphine Hydrochloride Injection Shortage
Last Updated: December 14, 2020
Status: Resolved
Products Affected - Description
-
- Buprenex injection, Indivior, 0.3 mg/mL, 1 mL ampule, 1 count, NDC 12496-0757-01 - discontinued
Reason for the Shortage
-
- Pfizer had buprenorphine injection on shortage due to manufacturing delays.
- Par had buprenorphine injection on shortage due to increased demand.
Available Products
-
- Buprenex injection, Indivior, 0.3 mg/mL, 1 mL ampule, 5 count, NDC 12496-0757-05
- Buprenorphine injection, Par Pharmaceuticals, 0.3 mg/mL, 1 mL vial, 5 count, NDC 42023-0179-05
- Buprenorphine injection, Pfizer, 0.3 mg/mL, 1 mL Carpuject syringe, 10 count, NDC 00409-2012-32
Estimated Resupply Dates
-
- All marketed presentations are available.
Updated
Updated December 14, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created April 27, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.